This is a Validated Antibody Database (VAD) review about dogs CD44, based on 107 published articles (read how Labome selects the articles), using CD44 antibody in all methods. It is aimed to help Labome visitors find the most suited CD44 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Invitrogen
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1e, s3
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1e, s3). Int J Mol Sci (2022) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 4b
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 4b). J Immunother Cancer (2021) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:1000; loading ...; fig s5
Invitrogen CD44 antibody (eBiosciences, IM7) was used in flow cytometry on mouse samples at 1:1000 (fig s5). Nat Commun (2021) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 4f
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 4f). Acta Naturae (2021) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...
Invitrogen CD44 antibody (Thermofisher, IM7) was used in flow cytometry on mouse samples . Protein Cell (2021) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 4b
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 4b). elife (2021) ncbi
mouse monoclonal (MEM-263)
  • flow cytometry; human; fig 3
Invitrogen CD44 antibody (Thermo Scientific, MEM-263) was used in flow cytometry on human samples (fig 3). Antioxidants (Basel) (2021) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200; loading ...; fig 5e
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples at 1:200 (fig 5e). elife (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 5d
Invitrogen CD44 antibody (Thermo Fisher, IM7) was used in flow cytometry on mouse samples (fig 5d). Front Immunol (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; domestic horse; 1:100; loading ...; fig 1c
Invitrogen CD44 antibody (Invitrogen, IM7) was used in flow cytometry on domestic horse samples at 1:100 (fig 1c). Animals (Basel) (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; loading ...; fig 4b
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on human samples (fig 4b). BMC Immunol (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; 1:100; loading ...; fig 6a
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on human samples at 1:100 (fig 6a). Front Immunol (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 6a
Invitrogen CD44 antibody (Thermo Fisher, IM7) was used in flow cytometry on mouse samples (fig 6a). Front Immunol (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200; loading ...; fig s1g
Invitrogen CD44 antibody (Thermo Fisher, IM7) was used in flow cytometry on mouse samples at 1:200 (fig s1g). Cell Rep (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2c
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 2c). Science (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1a, s1c
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1a, s1c). Sci Adv (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig e10
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig e10). Nature (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s4b
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig s4b). J Clin Invest (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 4
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 4). J Immunol (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1a
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1a). J Exp Med (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1e
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1e). Stem Cell Res Ther (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:100; loading ...
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples at 1:100. Nature (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1f
Invitrogen CD44 antibody (eBiosciences, IM7) was used in flow cytometry on mouse samples (fig 1f). J Exp Med (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1e
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1e). Oncoimmunology (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1a, 8b
Invitrogen CD44 antibody (eBiosciences, IM7) was used in flow cytometry on mouse samples (fig 1a, 8b). Nat Commun (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:400; loading ...; fig 6d
Invitrogen CD44 antibody (eBiosciences, IM7) was used in flow cytometry on mouse samples at 1:400 (fig 6d). Nat Commun (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1b
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1b). Proc Natl Acad Sci U S A (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s1a
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig s1a). Blood (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig ex7g
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig ex7g). Nature (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2a
Invitrogen CD44 antibody (Thermo Fisher Scientific, IM7) was used in flow cytometry on mouse samples (fig 2a). J Clin Invest (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2b
Invitrogen CD44 antibody (Thermo Fisher Scientific, IM-7) was used in flow cytometry on mouse samples (fig 2b). Eur J Immunol (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:300; loading ...; fig 1d
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples at 1:300 (fig 1d). Nat Commun (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:400; loading ...; fig s6a
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples at 1:400 (fig s6a). Nat Commun (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1e
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1e). Cell Death Dis (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig e4e
Invitrogen CD44 antibody (eBiosciences, IM7) was used in flow cytometry on mouse samples (fig e4e). Nature (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s2j
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig s2j). Science (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 6a
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 6a). Cancer Res (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 7e
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 7e). J Exp Med (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s3
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig s3). Front Immunol (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 5d
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 5d). J Clin Invest (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200; loading ...; fig 3a
Invitrogen CD44 antibody (Affymetrix/eBioscience, IM7) was used in flow cytometry on mouse samples at 1:200 (fig 3a). J Clin Invest (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1a
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1a). J Immunol (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1d
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1d). Front Immunol (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2a
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 2a). J Immunol (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1b
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1b). J Immunol (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 6b
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 6b). J Immunol (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 4f
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 4f). J Immunol (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s3g
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig s3g). Cancer Res (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 2b
Invitrogen CD44 antibody (Invitrogen, IM7) was used in flow cytometry on mouse samples (fig 2b). J Immunol (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 5b
In order to investigate the role of protease-activated receptor 2 in lymphocyte development, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 5b). Int J Biochem Cell Biol (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 3f
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 3f). J Immunol (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1d
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1d). J Immunol (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 4a
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 4a). Eur J Immunol (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1a
In order to study intestinal immune responses during acute graft-versus-host disease, Invitrogen CD44 antibody (eBiosciences, IM7) was used in flow cytometry on mouse samples (fig 1a). J Clin Invest (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 8a
In order to determine the role of RelB in classical dendritic cell and myeloid development, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 8a). Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1d
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1d). J Immunol (2017) ncbi
rat monoclonal (IM7)
  • blocking or activating experiments; human; loading ...
In order to implicate myeloid differentiation factor-2 as the high-affinity soluble CD83 binding partner, Invitrogen CD44 antibody (eBioscience, IM7) was used in blocking or activating experiments on human samples . J Immunol (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2a
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 2a). Blood (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; loading ...; fig 3e
In order to demonstrate that ADAM12 supports the cancer stem cell phenotype in claudin-low breast cancer cells via modulation of the epidermal growth factor receptor pathway, Invitrogen CD44 antibody (Affymetrix eBioscience, IM7) was used in flow cytometry on human samples (fig 3e). Mol Cancer (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2c
In order to evaluate miR-29a in B cells as a potential therapeutic target in arthritis, Invitrogen CD44 antibody (eBiosciences, IM7) was used in flow cytometry on mouse samples (fig 2c). Cell Mol Life Sci (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s1
In order to show that ABCA7 regulates natural killer T cell development in a cell-extrinsic manner, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig s1). Sci Rep (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1C
In order to evaluate the potential role of the attachment of myristic acid to the N-terminal glycine of proteins on the activation of gamma delta T cells, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1C). J Leukoc Biol (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2
In order to examine natural killer T cell development in mice deficient for SLAM family receptors, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 2). J Exp Med (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...
In order to determine that NKG2C/E identifies the CD4 T cell effector subset ThCTL that develop in the lung during influenza A virus infection in mice, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples . J Immunol (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 2a
  • immunocytochemistry; mouse; fig 2h
In order to explore the role of PKCalpha-DOCK8-Cdc42 signaling in T cell migration, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 2a) and in immunocytochemistry on mouse samples (fig 2h). J Exp Med (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 6a
In order to explore if the anti-diabetic sulphonylurea glibenclamide protects insulin-producing cells against conditions mimicking those expected at the onset of type 1 diabetes, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 6a). PLoS ONE (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:400; loading ...; fig s4a
Invitrogen CD44 antibody (eBiosciences, IM7) was used in flow cytometry on mouse samples at 1:400 (fig s4a). Nat Commun (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s1
In order to discuss differences in eosinophil degranulation between humans and mice, Invitrogen CD44 antibody (eBiosciences, M27) was used in flow cytometry on mouse samples (fig s1). Am J Respir Crit Care Med (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1b
In order to find a role for RAB43 in cross-presentation by classical dendritic cells, Invitrogen CD44 antibody (eBiosciences, IM7) was used in flow cytometry on mouse samples (fig 1b). J Exp Med (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...
In order to use knockout mice to determine if GRK6 contributes to hematopoiesis, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples . Cell Death Dis (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 3e
In order to characterize side population T cells, Invitrogen CD44 antibody (eBiosciences, IM7) was used in flow cytometry on mouse samples (fig 3e). J Clin Invest (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1b
In order to investigate the contribution of TGF-beta to the eomesodermin-driven CD4 T cell program during viral infection, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1b). J Clin Invest (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2c
In order to demonstrate that the negative regulation of T cell receptor signaling during natural killer T cell development regulates NKT1 and NKT2 differentiation and survival, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 2c). J Exp Med (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; pigs ; fig 1b
  • immunocytochemistry; pigs ; 1:100; fig 1a
In order to assess the presence of vitamin D machinery on porcine adipose-derived MSCs, Invitrogen CD44 antibody (eBiosciences, IM7) was used in flow cytometry on pigs samples (fig 1b) and in immunocytochemistry on pigs samples at 1:100 (fig 1a). Stem Cell Res Ther (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1e
In order to implement lck-cre transgenic mice to study the role of loxP-targeted genes in T cell development and function, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1e). J Immunol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 6f
In order to demonstrate that Blimp-1 controls CD4 T cell exhaustion, Invitrogen CD44 antibody (Affymetrix eBioscience, IM7) was used in flow cytometry on mouse samples (fig 6f). J Exp Med (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...
In order to study how IL-17 and IFN-gamma control Staphylococcus aureus infection, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples . Am J Pathol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1b
In order to use knockout mice to determine the role of cereblon in T cells, Invitrogen CD44 antibody (eBiosciences, IM7) was used in flow cytometry on mouse samples (fig 1b). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2
In order to report the effects of PD-L1 modulation of T cell function in graft-versus-host disease, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 2). J Clin Invest (2016) ncbi
rat monoclonal (IM7)
  • immunocytochemistry; human; 1:500; loading ...; fig s10
In order to elucidate cellular mechanisms that regulate the formation of clusters of circulating tumor cells, Invitrogen CD44 antibody (eBioscience, IM7) was used in immunocytochemistry on human samples at 1:500 (fig s10). J R Soc Interface (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig cd44
In order to propose that neuronal autoimmunity is a pathogenic feature of type 1 diabetes, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig cd44). Diabetes (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 7
In order to establish that autophagy is essential for maintenance of a balanced CD4 positive intestinal T cell response, Invitrogen CD44 antibody (eBioscience, 1M7) was used in flow cytometry on mouse samples (fig 7). elife (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1a
In order to report that the majority of microbe-specific naive T cells produced memory cells during infection, Invitrogen CD44 antibody (eBiosciences, IM7) was used in flow cytometry on mouse samples (fig 1a). Science (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...
In order to elucidate the role of miR-34a in efferocytosis, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples . J Immunol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; loading ...; fig 2a
In order to find that breast cancer stem cells isolated with CD44(+)CD24(-/lo)SSEA-3(+) or ESA(hi)PROCR(hi)SSEA-3(+) markers have higher tumorigenicity than those with conventional markers, Invitrogen CD44 antibody (eBioscience, IM-7) was used in flow cytometry on human samples (fig 2a). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s1
In order to study the polysialylation of CCR7, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig s1). Science (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...
In order to elucidate the role of TfR1 in adaptive immunity, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples . Nat Genet (2016) ncbi
rat monoclonal (IM7)
  • immunohistochemistry; mouse; 0.2 ug/ml; fig 2
In order to investigate how CD44 modulation induced resistance to type 1 diabetes in NOD mice, Invitrogen CD44 antibody (Thermo Scientific, MA1-10225) was used in immunohistochemistry on mouse samples at 0.2 ug/ml (fig 2). PLoS ONE (2015) ncbi
rat monoclonal (IM7)
  • immunohistochemistry - frozen section; human; 1:100; loading ...; fig 2e
  • flow cytometry; human; 1:100; fig 2g
  • immunocytochemistry; human; 1:100; fig 3e
In order to study the differentiation of oral mucosa stromal cells into neural crest stem cells and assess their therapeutic value, Invitrogen CD44 antibody (eBioscience, IM7) was used in immunohistochemistry - frozen section on human samples at 1:100 (fig 2e), in flow cytometry on human samples at 1:100 (fig 2g) and in immunocytochemistry on human samples at 1:100 (fig 3e). Stem Cells Transl Med (2016) ncbi
rat monoclonal (YKIX337.8)
  • flow cytometry; dogs; 1:2000; fig 5
  • immunocytochemistry; dogs; 1:500; fig 7
In order to determine the effects of cryopreservation on canine adipose-derived multipotent stromal cells, Invitrogen CD44 antibody (eBiosciences, 115440) was used in flow cytometry on dogs samples at 1:2000 (fig 5) and in immunocytochemistry on dogs samples at 1:500 (fig 7). Stem Cell Rev (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 7b
In order to find that lymph node-like vasculature in melanoma and lung carcinoma murine models is both a consequence of and key contributor to anti-tumor immunity, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 7b). Nat Commun (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1b
In order to assess a CD 4 T-cell population during tuberculosis that has memory-like properties maintained by Bcl6 and ICOS-dependent pathways, Invitrogen CD44 antibody (eBioscience, 1M7) was used in flow cytometry on mouse samples (fig 1b). J Exp Med (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 5
In order to show that the PTEN-mTORC2 axis maintains T regulatory cell stability and coordinates their control of effector responses, Invitrogen CD44 antibody (eBioscience, 1M7) was used in flow cytometry on mouse samples (fig 5). Nat Immunol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 3
In order to investigate the role of Rpl22 during early B cell development, Invitrogen CD44 antibody (eBioscience, 1M7) was used in flow cytometry on mouse samples (fig 3). J Immunol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 2a
In order to investigate the role of DUSP6 in colonic CD4 positive T-cell function, differentiation, and inflammatory profile, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 2a). Mucosal Immunol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to study the immunogenicity and immunomodulatory properties of bone marrow-derived mesenchymal stem cells using an allogeneic mouse model, Invitrogen CD44 antibody (Invitrogen, IM7) was used in flow cytometry on mouse samples . J Tissue Eng (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 4
In order to determine the roles of c-Myb during lymphocyte development, Invitrogen CD44 antibody (eBioscience, 1M7) was used in flow cytometry on mouse samples (fig 4). J Immunol (2009) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to evaluate the use of biodegradable poly(D,L-lactic-co-glycolic acid) nanoparticles as a vaccine delivery system, Invitrogen CD44 antibody (E-Bioscience, 1M7) was used in flow cytometry on mouse samples . J Biomed Mater Res A (2007) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to report two Treg subsets with distinct phenotypes and homeostasis in normal unmanipulated mice, Invitrogen CD44 antibody (Zymed, IM7) was used in flow cytometry on mouse samples . J Exp Med (2003) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1
In order to characterize murine tumor-infiltrating lymphocytes, Invitrogen CD44 antibody (CalTag, IM7) was used in flow cytometry on mouse samples (fig 1). J Immunol (2001) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1
In order to study CD44 and hyaluronic acid interactions, Invitrogen CD44 antibody (noco, IM7) was used in flow cytometry on mouse samples (fig 1). J Exp Med (1992) ncbi
Santa Cruz Biotechnology
rat monoclonal (IM7)
  • immunohistochemistry - paraffin section; mouse; 1:300; loading ...; fig 5e
Santa Cruz Biotechnology CD44 antibody (Santa Cruz Biotechnology, sc-18849) was used in immunohistochemistry - paraffin section on mouse samples at 1:300 (fig 5e). J Clin Invest (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 2
Santa Cruz Biotechnology CD44 antibody (Santa Cruz Biotechnology, sc-18849) was used in flow cytometry on mouse samples (fig 2). Cancer Res (2015) ncbi
rat monoclonal (IM7)
  • immunocytochemistry; human; fig 3
  • western blot; human; fig 3
Santa Cruz Biotechnology CD44 antibody (santa Cruz, sc-18849) was used in immunocytochemistry on human samples (fig 3) and in western blot on human samples (fig 3). Int J Mol Med (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; loading ...; fig 3a
Santa Cruz Biotechnology CD44 antibody (Santa Cruz, sc-18849) was used in flow cytometry on human samples (fig 3a). Cancer Res (2015) ncbi
rat monoclonal (IM7)
  • immunocytochemistry; mouse; 1:50
Santa Cruz Biotechnology CD44 antibody (Santa Cruz Biotech, sc-18849) was used in immunocytochemistry on mouse samples at 1:50. Reproduction (2010) ncbi
Bio-Rad
rat monoclonal (YKIX337.8.7)
  • flow cytometry; dogs
Bio-Rad CD44 antibody (Serotec, MCA1041A488) was used in flow cytometry on dogs samples . Acta Vet Scand (2014) ncbi
Articles Reviewed
  1. Keller E, Dvorina N, Jørgensen T. Spontaneous CD4+ T Cell Activation and Differentiation in Lupus-Prone B6.Nba2 Mice Is IFNAR-Independent. Int J Mol Sci. 2022;23: pubmed publisher
  2. Wang Z, He L, Li W, Xu C, Zhang J, Wang D, et al. GDF15 induces immunosuppression via CD48 on regulatory T cells in hepatocellular carcinoma. J Immunother Cancer. 2021;9: pubmed publisher
  3. Lacy M, Burger C, Shami A, Ahmadsei M, Winkels H, Nitz K, et al. Cell-specific and divergent roles of the CD40L-CD40 axis in atherosclerotic vascular disease. Nat Commun. 2021;12:3754 pubmed publisher
  4. Kalinina A, Khromykh L, Kazansky D, Deykin A, Silaeva Y. Suppression of the Immune Response by Syngeneic Splenocytes Adoptively Transferred to Sublethally Irradiated Mice. Acta Naturae. 2021;13:116-126 pubmed publisher
  5. Yuan J, Cai T, Zheng X, Ren Y, Qi J, Lu X, et al. Potentiating CD8+ T cell antitumor activity by inhibiting PCSK9 to promote LDLR-mediated TCR recycling and signaling. Protein Cell. 2021;12:240-260 pubmed publisher
  6. Angulo G, Železnjak J, Martínez Vicente P, Puñet Ortiz J, Hengel H, Messerle M, et al. Cytomegalovirus restricts ICOSL expression on antigen-presenting cells disabling T cell co-stimulation and contributing to immune evasion. elife. 2021;10: pubmed publisher
  7. Xiao L, Mochizuki M, Nakahara T, Miwa N. Hydrogen-Generating Silica Material Prevents UVA-ray-Induced Cellular Oxidative Stress, Cell Death, Collagen Loss and Melanogenesis in Human Cells and 3D Skin Equivalents. Antioxidants (Basel). 2021;10: pubmed publisher
  8. Jensen I, Jensen S, Sjaastad F, Gibson Corley K, Dileepan T, Griffith T, et al. Sepsis impedes EAE disease development and diminishes autoantigen-specific naive CD4 T cells. elife. 2020;9: pubmed publisher
  9. Myers D, Abram C, Wildes D, Belwafa A, Welsh A, Schulze C, et al. Shp1 Loss Enhances Macrophage Effector Function and Promotes Anti-Tumor Immunity. Front Immunol. 2020;11:576310 pubmed publisher
  10. Kim K, Park T, Cho B, Kim T. Nanoparticles from Equine Fetal Bone Marrow-Derived Cells Enhance the Survival of Injured Chondrocytes. Animals (Basel). 2020;10: pubmed publisher
  11. Liu G, Yu Y, Feng F, Zhu P, Zhang H, Zhang D, et al. Human CD8+CD28- T suppressor cells expanded by common gamma chain (γc) cytokines retain steady allospecific suppressive capacity in vivo. BMC Immunol. 2020;21:23 pubmed publisher
  12. Gao M, Wang T, Ji L, Bai S, Tian L, Song H. Therapy With Carboplatin and Anti-PD-1 Antibodies Before Surgery Demonstrates Sustainable Anti-Tumor Effects for Secondary Cancers in Mice With Triple-Negative Breast Cancer. Front Immunol. 2020;11:366 pubmed publisher
  13. Bell O, Copland D, Ward A, Nicholson L, Lange C, Chu C, et al. Single Eye mRNA-Seq Reveals Normalisation of the Retinal Microglial Transcriptome Following Acute Inflammation. Front Immunol. 2019;10:3033 pubmed publisher
  14. Li A, Herbst R, Canner D, Schenkel J, Smith O, Kim J, et al. IL-33 Signaling Alters Regulatory T Cell Diversity in Support of Tumor Development. Cell Rep. 2019;29:2998-3008.e8 pubmed publisher
  15. Leone R, Zhao L, Englert J, Sun I, Oh M, Sun I, et al. Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion. Science. 2019;366:1013-1021 pubmed publisher
  16. Lin F, Meng X, Guo Y, Cao W, Liu W, Xia Q, et al. Epigenetic initiation of the TH17 differentiation program is promoted by Cxxc finger protein 1. Sci Adv. 2019;5:eaax1608 pubmed publisher
  17. Majer O, Liu B, Kreuk L, Krogan N, Barton G. UNC93B1 recruits syntenin-1 to dampen TLR7 signalling and prevent autoimmunity. Nature. 2019;575:366-370 pubmed publisher
  18. Papaioannou E, Yanez D, Ross S, Lau C, Solanki A, Chawda M, et al. Sonic Hedgehog signaling limits atopic dermatitis via Gli2-driven immune regulation. J Clin Invest. 2019;129:3153-3170 pubmed publisher
  19. Khanom U, Ohigashi I, Fujimori S, Kondo K, Takada K, Takahama Y. TCR Affinity for In Vivo Peptide-Induced Thymic Positive Selection Fine-Tunes TCR Responsiveness of Peripheral CD8+ T Cells. J Immunol. 2019;: pubmed publisher
  20. Kotov J, Kotov D, Linehan J, Bardwell V, Gearhart M, Jenkins M. BCL6 corepressor contributes to Th17 cell formation by inhibiting Th17 fate suppressors. J Exp Med. 2019;216:1450-1464 pubmed publisher
  21. Lu D, Liao Y, Zhu S, Chen Q, Xie D, Liao J, et al. Bone-derived Nestin-positive mesenchymal stem cells improve cardiac function via recruiting cardiac endothelial cells after myocardial infarction. Stem Cell Res Ther. 2019;10:127 pubmed publisher
  22. Lee J, Stone M, Porrett P, Thomas S, Komar C, Li J, et al. Hepatocytes direct the formation of a pro-metastatic niche in the liver. Nature. 2019;567:249-252 pubmed publisher
  23. Xing S, Gai K, Li X, Shao P, Zeng Z, Zhao X, et al. Tcf1 and Lef1 are required for the immunosuppressive function of regulatory T cells. J Exp Med. 2019;: pubmed publisher
  24. Han Y, Feng H, Sun J, Liang X, Wang Z, Xing W, et al. Lkb1 deletion in periosteal mesenchymal progenitors induces osteogenic tumors through mTORC1 activation. J Clin Invest. 2019;130: pubmed publisher
  25. Salerno F, Guislain A, Freen van Heeren J, Nicolet B, Young H, Wolkers M. Critical role of post-transcriptional regulation for IFN-γ in tumor-infiltrating T cells. Oncoimmunology. 2019;8:e1532762 pubmed publisher
  26. Li F, Zeng Z, Xing S, Gullicksrud J, Shan Q, Choi J, et al. Ezh2 programs TFH differentiation by integrating phosphorylation-dependent activation of Bcl6 and polycomb-dependent repression of p19Arf. Nat Commun. 2018;9:5452 pubmed publisher
  27. Chorro L, Suzuki M, Chin S, Williams T, Snapp E, Odagiu L, et al. Interleukin 2 modulates thymic-derived regulatory T cell epigenetic landscape. Nat Commun. 2018;9:5368 pubmed publisher
  28. Atretkhany K, Mufazalov I, Dunst J, Kuchmiy A, Gogoleva V, Andruszewski D, et al. Intrinsic TNFR2 signaling in T regulatory cells provides protection in CNS autoimmunity. Proc Natl Acad Sci U S A. 2018;115:13051-13056 pubmed publisher
  29. Humblet Baron S, Barber J, Roca C, Lenaerts A, Koni P, Liston A. Murine myeloproliferative disorder as a consequence of impaired collaboration between dendritic cells and CD4 T cells. Blood. 2018;: pubmed publisher
  30. Song M, Sandoval T, Chae C, Chopra S, Tan C, Rutkowski M, et al. IRE1α-XBP1 controls T cell function in ovarian cancer by regulating mitochondrial activity. Nature. 2018;562:423-428 pubmed publisher
  31. Giles D, Duncker P, Wilkinson N, Washnock Schmid J, Segal B. CNS-resident classical DCs play a critical role in CNS autoimmune disease. J Clin Invest. 2018;128:5322-5334 pubmed publisher
  32. Baens M, Stirparo R, Lampi Y, Verbeke D, Vandepoel R, Cools J, et al. Malt1 self-cleavage is critical for regulatory T cell homeostasis and anti-tumor immunity in mice. Eur J Immunol. 2018;48:1728-1738 pubmed publisher
  33. Zhu L, Xie X, Zhang L, Wang H, Jie Z, Zhou X, et al. TBK-binding protein 1 regulates IL-15-induced autophagy and NKT cell survival. Nat Commun. 2018;9:2812 pubmed publisher
  34. Zhang C, Wang C, Jiang M, Gu C, Xiao J, Chen X, et al. Act1 is a negative regulator in T and B cells via direct inhibition of STAT3. Nat Commun. 2018;9:2745 pubmed publisher
  35. Feng Y, Liao Y, Huang W, Lai X, Luo J, Du C, et al. Mesenchymal stromal cells-derived matrix Gla protein contribute to the alleviation of experimental colitis. Cell Death Dis. 2018;9:691 pubmed publisher
  36. Du X, Wen J, Wang Y, Karmaus P, Khatamian A, Tan H, et al. Hippo/Mst signalling couples metabolic state and immune function of CD8α+ dendritic cells. Nature. 2018;558:141-145 pubmed publisher
  37. Ma C, Han M, Heinrich B, Fu Q, Zhang Q, Sandhu M, et al. Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells. Science. 2018;360: pubmed publisher
  38. Hu X, Majchrzak K, Liu X, Wyatt M, Spooner C, Moisan J, et al. In Vitro Priming of Adoptively Transferred T Cells with a RORγ Agonist Confers Durable Memory and Stemness In Vivo. Cancer Res. 2018;78:3888-3898 pubmed publisher
  39. Zhang Y, Tech L, George L, Acs A, Durrett R, Hess H, et al. Plasma cell output from germinal centers is regulated by signals from Tfh and stromal cells. J Exp Med. 2018;215:1227-1243 pubmed publisher
  40. Safya H, Mellouk A, Legrand J, Le Gall S, Benbijja M, Kanellopoulos Langevin C, et al. Variations in Cellular Responses of Mouse T Cells to Adenosine-5'-Triphosphate Stimulation Do Not Depend on P2X7 Receptor Expression Levels but on Their Activation and Differentiation Stage. Front Immunol. 2018;9:360 pubmed publisher
  41. Khan A, Carpenter B, Santos e Sousa P, Pospori C, Khorshed R, Griffin J, et al. Redirection to the bone marrow improves T cell persistence and antitumor functions. J Clin Invest. 2018;128:2010-2024 pubmed publisher
  42. Hailemichael Y, Woods A, Fu T, He Q, Nielsen M, Hasan F, et al. Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy. J Clin Invest. 2018;128:1338-1354 pubmed publisher
  43. Kotov D, Kotov J, Goldberg M, Jenkins M. Many Th Cell Subsets Have Fas Ligand-Dependent Cytotoxic Potential. J Immunol. 2018;200:2004-2012 pubmed publisher
  44. Ellestad K, Thangavelu G, Haile Y, Lin J, Boon L, Anderson C. Prior to Peripheral Tolerance, Newly Generated CD4 T Cells Maintain Dangerous Autoimmune Potential: Fas- and Perforin-Independent Autoimmunity Controlled by Programmed Death-1. Front Immunol. 2018;9:12 pubmed publisher
  45. Ferdinand J, Richard A, Meylan F, Al Shamkhani A, Siegel R. Cleavage of TL1A Differentially Regulates Its Effects on Innate and Adaptive Immune Cells. J Immunol. 2018;200:1360-1369 pubmed publisher
  46. Burrack A, Malhotra D, Dileepan T, Osum K, Swanson L, Fife B, et al. Cutting Edge: Allograft Rejection Is Associated with Weak T Cell Responses to Many Different Graft Leukocyte-Derived Peptides. J Immunol. 2018;200:477-482 pubmed publisher
  47. Ibitokou S, Dillon B, Sinha M, Szczesny B, Delgadillo A, Reda Abdelrahman D, et al. Early Inhibition of Fatty Acid Synthesis Reduces Generation of Memory Precursor Effector T Cells in Chronic Infection. J Immunol. 2018;200:643-656 pubmed publisher
  48. Ibrahim M, Scozzi D, Toth K, Ponti D, Kreisel D, Menna C, et al. Naive CD4+ T Cells Carrying a TLR2 Agonist Overcome TGF-β-Mediated Tumor Immune Evasion. J Immunol. 2018;200:847-856 pubmed publisher
  49. Kwak J, Laskowski J, Li H, McSharry M, Sippel T, Bullock B, et al. Complement Activation via a C3a Receptor Pathway Alters CD4+ T Lymphocytes and Mediates Lung Cancer Progression. Cancer Res. 2018;78:143-156 pubmed publisher
  50. Wasiuk A, Testa J, Weidlick J, Sisson C, Vitale L, Widger J, et al. CD27-Mediated Regulatory T Cell Depletion and Effector T Cell Costimulation Both Contribute to Antitumor Efficacy. J Immunol. 2017;199:4110-4123 pubmed publisher
  51. Francis N, Every A, Ayodele B, Pike R, Mackie E, Pagel C. A T cell-specific knockout reveals an important role for protease-activated receptor 2 in lymphocyte development. Int J Biochem Cell Biol. 2017;92:95-103 pubmed publisher
  52. Blanchfield L, Sabatino J, Lawrence L, Evavold B. NFM Cross-Reactivity to MOG Does Not Expand a Critical Threshold Level of High-Affinity T Cells Necessary for Onset of Demyelinating Disease. J Immunol. 2017;199:2680-2691 pubmed publisher
  53. Li L, Labuda J, Imai D, Griffey S, McSorley S. CCR7 Deficiency Allows Accelerated Clearance of Chlamydia from the Female Reproductive Tract. J Immunol. 2017;199:2547-2554 pubmed publisher
  54. Lino C, Barros Martins J, Oberdörfer L, Walzer T, Prinz I. Eomes expression reports the progressive differentiation of IFN-?-producing Th1-like ?? T cells. Eur J Immunol. 2017;47:970-981 pubmed publisher
  55. Bruce D, Stefanski H, Vincent B, Dant T, Reisdorf S, Bommiasamy H, et al. Type 2 innate lymphoid cells treat and prevent acute gastrointestinal graft-versus-host disease. J Clin Invest. 2017;127:1813-1825 pubmed publisher
  56. Briseño C, Gargaro M, Durai V, Davidson J, Theisen D, Anderson D, et al. Deficiency of transcription factor RelB perturbs myeloid and DC development by hematopoietic-extrinsic mechanisms. Proc Natl Acad Sci U S A. 2017;114:3957-3962 pubmed publisher
  57. Szabo P, Goswami A, Mazzuca D, Kim K, O Gorman D, Hess D, et al. Rapid and Rigorous IL-17A Production by a Distinct Subpopulation of Effector Memory T Lymphocytes Constitutes a Novel Mechanism of Toxic Shock Syndrome Immunopathology. J Immunol. 2017;198:2805-2818 pubmed publisher
  58. Horvatinovich J, Grogan E, Norris M, Steinkasserer A, Lemos H, Mellor A, et al. Soluble CD83 Inhibits T Cell Activation by Binding to the TLR4/MD-2 Complex on CD14+ Monocytes. J Immunol. 2017;198:2286-2301 pubmed publisher
  59. Asano T, Meguri Y, Yoshioka T, Kishi Y, Iwamoto M, Nakamura M, et al. PD-1 modulates regulatory T-cell homeostasis during low-dose interleukin-2 therapy. Blood. 2017;129:2186-2197 pubmed publisher
  60. Duhachek Muggy S, Qi Y, Wise R, Alyahya L, Li H, Hodge J, et al. Metalloprotease-disintegrin ADAM12 actively promotes the stem cell-like phenotype in claudin-low breast cancer. Mol Cancer. 2017;16:32 pubmed publisher
  61. van Nieuwenhuijze A, Dooley J, Humblet Baron S, Sreenivasan J, Koenders M, Schlenner S, et al. Defective germinal center B-cell response and reduced arthritic pathology in microRNA-29a-deficient mice. Cell Mol Life Sci. 2017;74:2095-2106 pubmed publisher
  62. Nowyhed H, Chandra S, Kiosses W, Marcovecchio P, Andary F, Zhao M, et al. ATP Binding Cassette Transporter ABCA7 Regulates NKT Cell Development and Function by Controlling CD1d Expression and Lipid Raft Content. Sci Rep. 2017;7:40273 pubmed publisher
  63. Rampoldi F, Brunk F, Bonrouhi M, Federico G, Krunic D, Porubsky S, et al. Deficiency of N-myristoylation reveals calcineurin activity as regulator of IFN-?-producing ?? T cells. J Leukoc Biol. 2017;101:1005-1014 pubmed publisher
  64. Chen S, Cai C, Li Z, Liu G, Wang Y, Blonska M, et al. Dissection of SAP-dependent and SAP-independent SLAM family signaling in NKT cell development and humoral immunity. J Exp Med. 2017;214:475-489 pubmed publisher
  65. Marshall N, Vong A, Devarajan P, Brauner M, Kuang Y, Nayar R, et al. NKG2C/E Marks the Unique Cytotoxic CD4 T Cell Subset, ThCTL, Generated by Influenza Infection. J Immunol. 2017;198:1142-1155 pubmed publisher
  66. Xu X, Han L, Zhao G, Xue S, Gao Y, Xiao J, et al. LRCH1 interferes with DOCK8-Cdc42-induced T cell migration and ameliorates experimental autoimmune encephalomyelitis. J Exp Med. 2017;214:209-226 pubmed publisher
  67. Lamprianou S, Gysemans C, Bou Saab J, Pontes H, Mathieu C, Meda P. Glibenclamide Prevents Diabetes in NOD Mice. PLoS ONE. 2016;11:e0168839 pubmed publisher
  68. Griffiths K, Ahmed M, Das S, Gopal R, Horne W, Connell T, et al. Targeting dendritic cells to accelerate T-cell activation overcomes a bottleneck in tuberculosis vaccine efficacy. Nat Commun. 2016;7:13894 pubmed publisher
  69. Jacobsen E, Ochkur S, Doyle A, Lesuer W, Li W, Protheroe C, et al. Lung Pathologies in a Chronic Inflammation Mouse Model Are Independent of Eosinophil Degranulation. Am J Respir Crit Care Med. 2017;195:1321-1332 pubmed publisher
  70. Kretzer N, Theisen D, Tussiwand R, Briseño C, Grajales Reyes G, Wu X, et al. RAB43 facilitates cross-presentation of cell-associated antigens by CD8?+ dendritic cells. J Exp Med. 2016;213:2871-2883 pubmed
  71. Le Q, Yao W, Chen Y, Yan B, Liu C, Yuan M, et al. GRK6 regulates ROS response and maintains hematopoietic stem cell self-renewal. Cell Death Dis. 2016;7:e2478 pubmed publisher
  72. Boddupalli C, Nair S, Gray S, Nowyhed H, Verma R, Gibson J, et al. ABC transporters and NR4A1 identify a quiescent subset of tissue-resident memory T cells. J Clin Invest. 2016;126:3905-3916 pubmed publisher
  73. Lewis G, Wehrens E, Labarta Bajo L, Streeck H, Zuniga E. TGF-? receptor maintains CD4 T helper cell identity during chronic viral infections. J Clin Invest. 2016;126:3799-3813 pubmed publisher
  74. Drennan M, Govindarajan S, Verheugen E, Coquet J, Staal J, McGuire C, et al. NKT sublineage specification and survival requires the ubiquitin-modifying enzyme TNFAIP3/A20. J Exp Med. 2016;213:1973-81 pubmed publisher
  75. Valle Y, Almalki S, Agrawal D. Vitamin D machinery and metabolism in porcine adipose-derived mesenchymal stem cells. Stem Cell Res Ther. 2016;7:118 pubmed publisher
  76. Carow B, Gao Y, Coquet J, Reilly M, Rottenberg M. lck-Driven Cre Expression Alters T Cell Development in the Thymus and the Frequencies and Functions of Peripheral T Cell Subsets. J Immunol. 2016;197:2261-8 pubmed publisher
  77. Hwang S, Cobb D, Bhadra R, Youngblood B, Khan I. Blimp-1-mediated CD4 T cell exhaustion causes CD8 T cell dysfunction during chronic toxoplasmosis. J Exp Med. 2016;213:1799-818 pubmed publisher
  78. Barin J, Talor M, Schaub J, Diny N, Hou X, Hoyer M, et al. Collaborative Interferon-? and Interleukin-17 Signaling Protects the Oral Mucosa from Staphylococcus aureus. Am J Pathol. 2016;186:2337-52 pubmed publisher
  79. Kang J, Park S, Jeong S, Han M, Lee C, Lee K, et al. Epigenetic regulation of Kcna3-encoding Kv1.3 potassium channel by cereblon contributes to regulation of CD4+ T-cell activation. Proc Natl Acad Sci U S A. 2016;113:8771-6 pubmed publisher
  80. Saha A, O Connor R, Thangavelu G, Lovitch S, Dandamudi D, Wilson C, et al. Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality. J Clin Invest. 2016;126:2642-60 pubmed publisher
  81. Boareto M, Jolly M, Goldman A, Pietila M, Mani S, Sengupta S, et al. Notch-Jagged signalling can give rise to clusters of cells exhibiting a hybrid epithelial/mesenchymal phenotype. J R Soc Interface. 2016;13: pubmed publisher
  82. Leeth C, Racine J, Chapman H, Arpa B, Carrillo J, Carrascal J, et al. B-lymphocytes expressing an Ig specificity recognizing the pancreatic ß-cell autoantigen peripherin are potent contributors to type 1 diabetes development in NOD mice. Diabetes. 2016;65:1977-1987 pubmed publisher
  83. Kabat A, Harrison O, Riffelmacher T, Moghaddam A, Pearson C, Laing A, et al. The autophagy gene Atg16l1 differentially regulates Treg and TH2 cells to control intestinal inflammation. elife. 2016;5:e12444 pubmed publisher
  84. Tubo N, Fife B, Pagán A, Kotov D, Goldberg M, Jenkins M. Most microbe-specific naïve CD4? T cells produce memory cells during infection. Science. 2016;351:511-4 pubmed publisher
  85. McCubbrey A, Nelson J, Stolberg V, Blakely P, McCloskey L, Janssen W, et al. MicroRNA-34a Negatively Regulates Efferocytosis by Tissue Macrophages in Part via SIRT1. J Immunol. 2016;196:1366-75 pubmed publisher
  86. Cheung S, Chuang P, Huang H, Hwang Verslues W, Cho C, Yang W, et al. Stage-specific embryonic antigen-3 (SSEA-3) and β3GalT5 are cancer specific and significant markers for breast cancer stem cells. Proc Natl Acad Sci U S A. 2016;113:960-5 pubmed publisher
  87. Kiermaier E, Moussion C, Veldkamp C, Gerardy Schahn R, de Vries I, Williams L, et al. Polysialylation controls dendritic cell trafficking by regulating chemokine recognition. Science. 2016;351:186-90 pubmed publisher
  88. Jabara H, Boyden S, Chou J, Ramesh N, Massaad M, Benson H, et al. A missense mutation in TFRC, encoding transferrin receptor 1, causes combined immunodeficiency. Nat Genet. 2016;48:74-8 pubmed publisher
  89. Assayag Asherie N, Sever D, Bogdani M, Johnson P, Weiss T, Ginzberg A, et al. Can CD44 Be a Mediator of Cell Destruction? The Challenge of Type 1 Diabetes. PLoS ONE. 2015;10:e0143589 pubmed publisher
  90. Abe S, Yamaguchi S, Sato Y, Harada K. Sphere-Derived Multipotent Progenitor Cells Obtained From Human Oral Mucosa Are Enriched in Neural Crest Cells. Stem Cells Transl Med. 2016;5:117-28 pubmed publisher
  91. Duan W, Lopez M. Effects of Cryopreservation on Canine Multipotent Stromal Cells from Subcutaneous and Infrapatellar Adipose Tissue. Stem Cell Rev. 2016;12:257-68 pubmed publisher
  92. Liang Y, Hu J, Li J, Liu Y, Yu J, Zhuang X, et al. Epigenetic Activation of TWIST1 by MTDH Promotes Cancer Stem-like Cell Traits in Breast Cancer. Cancer Res. 2015;75:3672-80 pubmed publisher
  93. Li L, Qi L, Liang Z, Song W, Liu Y, Wang Y, et al. Transforming growth factor-β1 induces EMT by the transactivation of epidermal growth factor signaling through HA/CD44 in lung and breast cancer cells. Int J Mol Med. 2015;36:113-22 pubmed publisher
  94. Peske J, Thompson E, Gemta L, Baylis R, Fu Y, Engelhard V. Effector lymphocyte-induced lymph node-like vasculature enables naive T-cell entry into tumours and enhanced anti-tumour immunity. Nat Commun. 2015;6:7114 pubmed publisher
  95. Moguche A, Shafiani S, Clemons C, Larson R, Dinh C, Higdon L, et al. ICOS and Bcl6-dependent pathways maintain a CD4 T cell population with memory-like properties during tuberculosis. J Exp Med. 2015;212:715-28 pubmed publisher
  96. Shrestha S, Yang K, Guy C, Vogel P, Neale G, Chi H. Treg cells require the phosphatase PTEN to restrain TH1 and TFH cell responses. Nat Immunol. 2015;16:178-87 pubmed publisher
  97. Fahl S, Harris B, Coffey F, Wiest D. Rpl22 Loss Impairs the Development of B Lymphocytes by Activating a p53-Dependent Checkpoint. J Immunol. 2015;194:200-9 pubmed
  98. Ghotra V, He S, van der Horst G, Nijhoff S, de Bont H, Lekkerkerker A, et al. SYK is a candidate kinase target for the treatment of advanced prostate cancer. Cancer Res. 2015;75:230-40 pubmed publisher
  99. Bertin S, Lozano Ruiz B, Bachiller V, García Martínez I, Herdman S, Zapater P, et al. Dual-specificity phosphatase 6 regulates CD4+ T-cell functions and restrains spontaneous colitis in IL-10-deficient mice. Mucosal Immunol. 2015;8:505-15 pubmed publisher
  100. Mukonoweshuro B, Brown C, Fisher J, Ingham E. Immunogenicity of undifferentiated and differentiated allogeneic mouse mesenchymal stem cells. J Tissue Eng. 2014;5:2041731414534255 pubmed publisher
  101. Kang M, Park H. Evaluation of adverse reactions in dogs following intravenous mesenchymal stem cell transplantation. Acta Vet Scand. 2014;56:16 pubmed publisher
  102. Yuan F, Li X, Lin J, Schwabe C, Bullesbach E, Rao C, et al. The role of RXFP2 in mediating androgen-induced inguinoscrotal testis descent in LH receptor knockout mice. Reproduction. 2010;139:759-69 pubmed publisher
  103. Fahl S, Crittenden R, Allman D, Bender T. c-Myb is required for pro-B cell differentiation. J Immunol. 2009;183:5582-92 pubmed publisher
  104. Hamdy S, Elamanchili P, Alshamsan A, Molavi O, Satou T, Samuel J. Enhanced antigen-specific primary CD4+ and CD8+ responses by codelivery of ovalbumin and toll-like receptor ligand monophosphoryl lipid A in poly(D,L-lactic-co-glycolic acid) nanoparticles. J Biomed Mater Res A. 2007;81:652-62 pubmed
  105. Fisson S, Darrasse Jèze G, Litvinova E, Septier F, Klatzmann D, Liblau R, et al. Continuous activation of autoreactive CD4+ CD25+ regulatory T cells in the steady state. J Exp Med. 2003;198:737-46 pubmed
  106. Radoja S, Saio M, Frey A. CD8+ tumor-infiltrating lymphocytes are primed for Fas-mediated activation-induced cell death but are not apoptotic in situ. J Immunol. 2001;166:6074-83 pubmed
  107. Lesley J, He Q, Miyake K, Hamann A, Hyman R, Kincade P. Requirements for hyaluronic acid binding by CD44: a role for the cytoplasmic domain and activation by antibody. J Exp Med. 1992;175:257-66 pubmed